The Interaction of Botrocetin with Normal or Variant von Willebrand Factor (Types IIA and IIB) and Its Inhibition by Monoclonal Antibodies that Block Receptor BindingYoshihiro Fujimura, Koiti Titani, Shigeki Miyata et al.|Thrombosis and Haemostasis|1992Cited by 17
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Cancer Research Communications|2024Cited by 7
Data from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Unknown|2024Cited by 0
Figure 3 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Unknown|2024Cited by 0
Figure 1 from Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor EndotheliumJason W.‐L. Eng, Jan Kitajewski, Yu Kato et al.|Unknown|2024Cited by 0